111 related articles for article (PubMed ID: 32419136)
1. Clinical outcomes of composite and sequential B-cell lymphomas with features intermediate between DLBCL/PMBCL and classical Hodgkin Lymphoma from the SEER database.
Shivarov V; Ivanova M
Br J Haematol; 2020 Aug; 190(3):464-466. PubMed ID: 32419136
[No Abstract] [Full Text] [Related]
2. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
Tao Y; Chen H; Liu D; Dai X
Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
[TBL] [Abstract][Full Text] [Related]
3. Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases.
Aussedat G; Traverse-Glehen A; Stamatoullas A; Molina T; Safar V; Laurent C; Michot JM; Hirsch P; Nicolas-Virelizier E; Lamure S; Regny C; Picquenot JM; Ledoux-Pilon A; Tas P; Chassagne-Clément C; Manson G; Lemal R; Fontaine J; Le Cann M; Salles G; Ghesquières H; Copie-Bergman C; Sarkozy C
Br J Haematol; 2020 Apr; 189(2):244-256. PubMed ID: 32030731
[TBL] [Abstract][Full Text] [Related]
4. A case of composite classical and nodular lymphocyte predominant Hodgkin lymphoma with progression to diffuse large B-cell non-Hodgkin lymphoma: Diagnostic difficulty in fine-needle aspiration cytology.
Das DK; Sheikh ZA; Al-Shama'a MH; John B; Alawi AM; Junaid TA
Diagn Cytopathol; 2017 Mar; 45(3):262-266. PubMed ID: 27888658
[TBL] [Abstract][Full Text] [Related]
5. Composite lymphoma with diffuse large B-cell lymphoma and classical Hodgkin lymphoma components: A case report and review of the literature.
Goyal G; Nguyen AH; Kendric K; Caponetti GC
Pathol Res Pract; 2016 Dec; 212(12):1179-1190. PubMed ID: 27887763
[TBL] [Abstract][Full Text] [Related]
6. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
[TBL] [Abstract][Full Text] [Related]
7. [Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
Wang L; Wang W; Li X; Guo Y; Zhu X
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):307-12. PubMed ID: 25030862
[TBL] [Abstract][Full Text] [Related]
8. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
9. [Clinical Characteristics and Prognosis of 56 Lymphoma Patients with Mediastinal Masses].
Yu H; Wang L; Zhu HY; Wu W; Liang JH; Yin H; Fan L; Li JY; Xu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):495-499. PubMed ID: 32319385
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):376-81. PubMed ID: 22932404
[TBL] [Abstract][Full Text] [Related]
11. The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma.
Tomassetti S; Chen R; Dandapani S
Ther Adv Hematol; 2019; 10():2040620719841591. PubMed ID: 31040936
[TBL] [Abstract][Full Text] [Related]
12. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
Tian X; Xu J; Dorfman DM
Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Myers RM; Hill BT; Shaw BE; Kim S; Millard HR; Battiwalla M; Majhail NS; Buchbinder D; Lazarus HM; Savani BN; Flowers MED; D'Souza A; Ehrhardt MJ; Langston A; Yared JA; Hayashi RJ; Daly A; Olsson RF; Inamoto Y; Malone AK; DeFilipp Z; Margossian SP; Warwick AB; Jaglowski S; Beitinjaneh A; Fung H; Kasow KA; Marks DI; Reynolds J; Stockerl-Goldstein K; Wirk B; Wood WA; Hamadani M; Satwani P
Cancer; 2018 Feb; 124(4):816-825. PubMed ID: 29125192
[TBL] [Abstract][Full Text] [Related]
14. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
15. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
Savage KJ; Monti S; Kutok JL; Cattoretti G; Neuberg D; De Leval L; Kurtin P; Dal Cin P; Ladd C; Feuerhake F; Aguiar RC; Li S; Salles G; Berger F; Jing W; Pinkus GS; Habermann T; Dalla-Favera R; Harris NL; Aster JC; Golub TR; Shipp MA
Blood; 2003 Dec; 102(12):3871-9. PubMed ID: 12933571
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A Proposed Scoring System.
O'Malley DP; Fedoriw Y; Weiss LM
Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):535-40. PubMed ID: 26447896
[TBL] [Abstract][Full Text] [Related]
17. Repeated clonal relapses in classical Hodgkin's lymphoma and the occurrence of a clonally unrelated diffuse large B cell non-Hodgkin lymphoma in the same patient.
Thomas RK; Wickenhauser C; Kube D; Tesch H; Diehl V; Wolf J; Vockerodt M
Leuk Lymphoma; 2004 May; 45(5):1065-9. PubMed ID: 15291369
[TBL] [Abstract][Full Text] [Related]
18. Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma.
Makita S; Maeshima AM; Taniguchi H; Kitahara H; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Kobayashi Y; Tobinai K
Int J Hematol; 2016 Sep; 104(3):396-9. PubMed ID: 27169615
[TBL] [Abstract][Full Text] [Related]
19. PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas.
Xie W; Medeiros LJ; Li S; Yin CC; Khoury JD; Xu J
Curr Hematol Malig Rep; 2020 Aug; 15(4):372-381. PubMed ID: 32394185
[TBL] [Abstract][Full Text] [Related]
20. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.
Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE
Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
